InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by RICKS THOMAS G, Director. Director active across 2 companies, notably Sensei Biotherapeutics, Inc.. Aggregated, 9 reports have been recorded. Breakdown: 3 buys · 3 sells. Total volume traded: €2.3m. Activity tracked since 9 December 2021. The latest transaction was filed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
4,466 shares0Common StockSEC:0001209191-22-036668:0
19,231 shares@ US$59.500.0063% mcap52.5% of flowCommon StockSEC:0001667731-22-000238:0
10,000 shares@ US$50.000.0028% mcap23.0% of flowCommon StockSEC:0001667731-22-000222:0
4,499 sharesCommon StockSEC:0001667731-22-000218:0
10,000 shares@ US$53.730.0030% mcap24.5% of flowCommon StockSEC:0001667731-22-000169:0
19 sharesCommon StockSEC:0001667731-22-000144:0
Ideal exit: 26 Dec 2022 (T+270)
5,184 sharesCommon StockSEC:0001667731-22-000087:0
20,000 shares@ US$6.620.43% mcap100.0% of flowCommon StockSEC:0000899243-21-047890
Ideal exit: 5 Sept 2022 (T+270)
20,000 shares@ US$6.620.43% mcap50.0% of flowCommon StockSEC:0000899243-21-047890:0
Ideal exit: 5 Sept 2022 (T+270)
9 of 9 declarations
About RICKS THOMAS G
Thomas G. Ricks serves as a Director of Sensei Biotherapeutics, Inc. and Ovintiv Inc. As a board member, he contributes to the strategic oversight of the companies and key decision-making regarding their future. Thomas brings expertise in biotechnology and energy, which is crucial for the growth and innovation of the businesses. His commitment to corporate governance is essential for ensuring transparency and accountability.
